Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas H Graversen

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory ChangesPia Svendsen, Jonas H Graversen, Anders Etzerodt, et al.
Hepatology Communications|June 28, 2023
The prevalence and risk factors for cognitive impairment in obesity and NAFLDCharlotte W Wernberg, Lea L Grønkjær, Birgitte Gade Jacobsen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2012
Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasoneJonas H Graversen, Pia Svendsen, Frederik Dagnæs-Hansen, et al.
Biochemistry and Biophysics Reports|June 12, 2026
Structural and functional characterization of human kallistatinStephanie T D Pham, Kristian W Nielsen, Jonas H Graversen, et al.
Frontiers in Immunology|August 16, 2018
CL-L1 and CL-K1 Exhibit Widespread Tissue Distribution With High and Co-Localized Expression in Secretory Epithelia and MucosaSoren W K Hansen, Josephine B Aagaard, Karen B Bjerrum, et al.
Brain Communications|April 30, 2020
Haemoglobin causes neuronal damage <i>in vivo</i> which is preventable by haptoglobinPatrick Garland, Matthew J Morton, William Haskins, et al.
JHEP Reports : Innovation in Hepatology|January 23, 2023
Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severityFrederik T Larsen, Daniel Hansen, Mike K Terkelsen, et al.
Cell Reports|March 19, 2020
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of ActomyosinSophie Uzureau, Laurence Lecordier, Pierrick Uzureau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2025
Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakageAnders Schlosser, Bartosz Pilecki, Claire Allen, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory ChangesPia Svendsen, Jonas H Graversen, Anders Etzerodt, et al.
Hepatology Communications|June 28, 2023
The prevalence and risk factors for cognitive impairment in obesity and NAFLDCharlotte W Wernberg, Lea L Grønkjær, Birgitte Gade Jacobsen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2012
Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasoneJonas H Graversen, Pia Svendsen, Frederik Dagnæs-Hansen, et al.
Biochemistry and Biophysics Reports|June 12, 2026
Structural and functional characterization of human kallistatinStephanie T D Pham, Kristian W Nielsen, Jonas H Graversen, et al.
Frontiers in Immunology|August 16, 2018
CL-L1 and CL-K1 Exhibit Widespread Tissue Distribution With High and Co-Localized Expression in Secretory Epithelia and MucosaSoren W K Hansen, Josephine B Aagaard, Karen B Bjerrum, et al.
Brain Communications|April 30, 2020
Haemoglobin causes neuronal damage <i>in vivo</i> which is preventable by haptoglobinPatrick Garland, Matthew J Morton, William Haskins, et al.
JHEP Reports : Innovation in Hepatology|January 23, 2023
Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severityFrederik T Larsen, Daniel Hansen, Mike K Terkelsen, et al.
Cell Reports|March 19, 2020
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of ActomyosinSophie Uzureau, Laurence Lecordier, Pierrick Uzureau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2025
Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakageAnders Schlosser, Bartosz Pilecki, Claire Allen, et al.
Pageof 2